Peregrine Enters Contract Negotiations With U.S. DTRA for Hemorrhagic Fevers
about bavituximab, activity, antips, antiviral, avid bioservices, award, barbara lindheim, bavituximab, cancer, clinical, com partners investors media, contract, defense, defense threat reduction agency, dtra, forwardlooking, forwardlooking statements, hcv, lindheim bio, peregrine, peregrine enters contract negotiations with u., peregrine pharmaceuticals, private securities litigation reform act, proposal, safe harbor statement, statements, steven w. king, threat, transformational medical technologies initiative, trials, united states, virus